TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
邵幼雲SHAO, YU-YUN
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
83筆
61
Yu-Yun Shao, Wen-Yi Shau, Zhong-Zhe Lin, Ho-Min Chen, Raymond Kuo, James Chih-Hsin Yang, Mei-Shu Lai. Comparison of Gefitinib and Erlotinib Efficacies as Third-Line Therapy for Advanced Non-Small-Cell Lung Cancer. Eur J Cancer 2013 Jan;49: 106–114#
62
Yu-Yun Shao*, Chi-Long Chen*, Ming-Chih Ho, Chien-Chung Huang, Hui-Ching Tu, Chih-Hung Hsu and Ann-Lii Cheng. Dissimilar Immunohistochemical Expression of ERK and AKT between Paired Biopsy and Hepatectomy Tissues of Hepatocellular Carcinoma. Anticancer Research 2012 Nov;32: 4865-4870 (*co-first authors)#
63
Yu-Yun Shao, Li-Chun Lu, Zhong-Zhe Lin, Chiun Hsu, Ying-Chun Shen, Chih-Hung Hsu, Ann-Lii Cheng. Prognosis of Advanced Hepatocellular Carcinoma Patients Enrolled in Clinical Trials Can Be Classified by Current Staging Systems. Brit J Cancer 2012 Nov; 107: 1672-1677#
64
Zhong-Zhe Lin, Wen-Yi Shau, Yu-Yun Shao, Yen-Yun Yang, Raymond Nien-Chen Kuo, James Chih-Hsin Yang, Mei-Shu Lai. Survival Following Surgery with or without Adjuvant Chemotherapy for Stage I–IIIA Non-Small Cell Lung Cancer: An East Asian Population-Based Study. The Oncologist 2012 Oct; 17:1294-1302#
65
Li-Chun Lu, Yu-Yun Shao, Chih-Hung Hsu, Chiun Hsu, Wen-Fang Cheng, Yu-Lin Lin, Ann-Lii Cheng, Kun-Huei Yeh. Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric Cancer. Anticancer Research 2012 Aug; 32: 3397-3402#
66
Zhong-Zhe Lin, Chiun Hsu, Fu-Chang Hu, Yu-Yun Shao, Dwan-Ying Chang, Chih-Hsin Yang, Ruey-Long Hong, Chih-Hung Hsu, Ann-Lii Cheng. Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy. The Oncologist 2012 Jul; 17:970-977#
67
Wen-Yi Shau*, Yu-Yun Shao*, Yi-Chun Yeh, Zhong-Zhe Lin, Raymond Kuo, Chih-Hung Hsu, Chiun Hsu, Ann-Lii Cheng, Mei-Shu Lai. Diabetes Mellitus Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma. The Oncologist 2012 Jun;17: 856-862 (*co-first authors)#
68
Yu-Yun Shao, Chien-Chung Huang, Shiou-Der Lin, Chih-Hung Hsu, Ann-Lii Cheng. Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Anti-Angiogenic Therapy. Clinical Cancer Research 2012 Jul; 18: 3992-3997#
69
Wei-Wu Chen*, Yu-Yun Shao*, Wen-Yi Shau, Zhong-Zhe Lin, Yen-Shen Lu, Ho-Min Chen, Raymond N Kuo, Ann-Lii Cheng, Mei-Shu Lai. The Impact of Diabetes Mellitus on Prognosis of Early Breast Cancer in Asia. The Oncologist 2012 Apr; 17: 485-491 (*co-first authors)#
70
Yu-Yun Shao, Zhong-Zhe Lin, Chiun Hsu, Kuan-Der Lee, Chi-Huang Hsiao, Yen-Shen Lu, Chien-Chung Huang, Yin-Chun Shen, Chih-Hung Hsu, Ann-Lii Cheng. Efficacy, Safety and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma. Oncology 2012 Feb; 82: 59-66#
